Chimerix has been granted a patent for pyrrolopyrimidine nucleoside analogs and phospholipid conjugates for treating viral infections and associated diseases. The compounds of Formula I, IA, IB, or II show promise in preventing and treating viral infections. GlobalData’s report on Chimerix gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Chimerix, Human telomerase RT biomarker was a key innovation area identified from patents. Chimerix's grant share as of May 2024 was 39%. Grant share is based on the ratio of number of grants to total number of patents.
Antiviral compounds for treating viral infections
A recently granted patent (Publication Number: US11981700B2) discloses a compound with various specific embodiments, including compound numbers 7, 8, 10, 66, 129, 130, 134, 136, 9, 56, and 127. These compounds are part of a pharmaceutical composition described in the patent, which also includes pharmaceutically acceptable forms such as salts, solvates, enantiomers, diastereomers, racemates, or mixtures thereof. The composition is formulated with a pharmaceutically acceptable carrier for potential use in the medical field.
The patent's claims outline the specific compounds that are part of the invention, highlighting their unique identification numbers and their role within the pharmaceutical composition. By including various compounds and their acceptable forms, the patent aims to cover a broad range of potential applications and formulations for the disclosed invention. This comprehensive approach to compound selection and formulation in the patent sets the stage for potential future developments and commercialization opportunities in the pharmaceutical industry.
To know more about GlobalData’s detailed insights on Chimerix, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
